SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-304849
Filing Date
2022-12-14
Accepted
2022-12-14 16:32:46
Documents
12
Period of Report
2022-12-09
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d438125d8k.htm   iXBRL 8-K 24597
  Complete submission text file 0001193125-22-304849.txt   152648

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vor-20221209.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20221209_lab.xml EX-101.LAB 19502
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20221209_pre.xml EX-101.PRE 12159
6 EXTRACTED XBRL INSTANCE DOCUMENT d438125d8k_htm.xml XML 3582
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 221462573
SIC: 2836 Biological Products, (No Diagnostic Substances)